Advanced Biomed

Advanced Biomed

Software
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

$8.1M

Market Cap • 10/15/2026

2021

(5 years)

Founded

2025

(1 year ago)

IPO

NASDAQ

Listing Exchange

Flag of Taiwan

Taiwan

Country

Valuation

P/B

0,7

P/S

63,2

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

0,9

BVPS

7,4

EPS

5,3

Market Cap

Market Cap

8,1M

EV

7,7M

EV/Revenue

60,1

EV/EBITDA

-1,2

EV/EBIT

-1,2

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-3,1%

Total Yield

-3,1%

Payout

0%

Retained Earnings

-12,6M

Profitability

Gross Margin

100%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

0%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Op. Income 5Y

27,7%

CAGR Net Income 5Y

27,8%

CAGR OCF 5Y

32,7%

Leverage

N.D./EBITDA

0,1

Debt/Equity

0%

Current Ratio

9,3

Quick Ratio

0,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium